Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Tumor cell lysis by natural killer cell-mediated cytotoxicity** refers to the process by which NK cells identify and kill tumor (and virally infected) cells. NK cells are cytotoxic lymphocytes of the innate immune system that respond to abnormal cells lacking appropriate MHC I molecules or expressing stress-induced ligands. They induce target cell death by two main pathways: - **Granule exocytosis**: NK cells release perforin and granzymes, which enter the target cell to induce apoptosis or lysis[1][2][3][4][5][6]. - **Death receptor–mediated apoptosis**: NK cells express death ligands like FasL or TRAIL that trigger extrinsic apoptotic pathways upon binding to their receptors on target cells[1][4][6]. NK cells can also mediate antibody-dependent cell-mediated cytotoxicity (ADCC) via their FcγRIII (CD16) receptors, killing antibody-coated targets[3][6]. This process is central in early control of malignancy and viral infection, and its mechanisms are leveraged in cancer immunotherapy[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell lysis by natural killer cell-mediated cytotoxicity.